• AAPL 167.04
  • TSLA 149.9
  • AMZN 179.17
  • MSFT 404.33
  • INTC 35.04
  • EURUSD 1.0622
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. RECEF.PINK

Recce Pharmaceuticals Ltd (RECEF PINK) stock market data APIs

$0.461 0(0%) as of April 18, 2024

Recce Pharmaceuticals Ltd Financial Data Overview

0.461
0.461
-
0.461
0.461
0.461-0.6
94 022 K
204 M
6 747 K
1.271
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RECEF',
Type: 'Common Stock',
Name: 'Recce Pharmaceuticals Ltd',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00RHNFXV8',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Recce Pharmaceuticals Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 6 747 K
  • EBITDA -10 683 716
  • Earnings Per Share -0.05
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Recce Pharmaceuticals Ltd Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Recce Pharmaceuticals Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Recce Pharmaceuticals Ltd latest news via APIs

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong, Strengthening Global IP Portfolio

Recce Pharmaceuticals SYDNEY, Australia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infective...
  • ANTI-INFECTIVES
  • GRAM-NEGATIVE BACTERIA
  • HONG KONG
  • JAMES GRAHAM
  • PHARMACEUTICAL MARKET
  • PHARMACEUTICAL PREPARATIONS
  • PHARMACEUTICALS
  • SYNTHETIC POLYMER
  • THE COMPANY
  • TRADE MARKS REGISTRY INTELLECTUAL PROPERTY DEPARTMENT

Recce Pharmaceuticals Receives A$6.21 Million from Research and Development (R&D) Rebate Payments

Recce Pharmaceuticals SYDNEY, Australia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infective...
  • ADVANCE PAYMENT
  • ANTI-INFECTIVES
  • AUSTRALIAN TAX OFFICE
  • CASH RECEIPT
  • COMPANY
  • JAMES GRAHAM
  • PHARMACEUTICALS
  • RADIUM
  • THE COMPANY
Do you have any questions?
support@eodhistoricaldata.com